Hematopathology

Research output

Research output per year 2004 2018 2019 2020 2021 2022 2023 2024

• 130 Article
• 35 Letter
• 4 Review article
• 2 Comment/debate

Research output per year

Research output per year

Search results

• 2024

  Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients

  Gagnon, M. F., Bruehl, F. K., Sill, D. R., Meyer, R. G., Greipp, P. T., Hoppman, N. L., Xu, X., Baughn, L. B., Peterson, J. F., McPhail, E. D., Ketterling, R. P. & King, R. L., 2024, (Accepted/In press) In: Journal of Hematopathology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • B-Cell Lymphoma 100%
  • Cytogenetics 95%
  • Young Adult 78%
  • Pediatrics 62%
  • Non-Hodgkin's Lymphoma 36%

• Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma A Mayo Clinic Clinical and Pathologic Study

  Khurana, S., Heckman, M. G., Craig, F. E., Cochuyt, J. J., Greipp, P., Rahman, Z. A., Sproat, L., Litzow, M., Foran, J. M. & Jiang, L. J., Apr 2024, In: Archives of Pathology and Laboratory Medicine. 148, 4 April, p. 471-475 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • CCR4 Receptors 100%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 56%
  • Clinical Studies 40%
  • T-Lymphocytes 35%
  • Tumor Biomarkers 9%

• Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms

  Baranwal, A., Basmaci, R., He, R., Viswanatha, D., Greipp, P., Murthy, H. S., Foran, J., Palmer, J., Hogan, W., Litzow, M. R., Hefazi, M., Mangaonkar, A., Shah, M. V., Al-Kali, A. & Alkhateeb, H. B., Feb 13 2024, In: Blood Advances. 8, 3, p. 562-570 9 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Superior detection rate of plasma cell FISH using FACS-FISH

  Gagnon, M. F., Midthun, S. M., Fangel, J. A., Schuh, C. M., Luoma, I. M., Pearce, K. E., Meyer, R. G., Ailawadhi, S., Arribas, M. J., Braggio, E., Fonseca, R., Rajkumar, S. V., Zepeda-Mendoza, C., Xu, X., Greipp, P. T., Timm, M. M., Otteson, G. E., Shi, M., Jevremovic, D., Olteanu, H., & 4 othersPeterson, J. F., Ketterling, R. P., Kumar, S. & Baughn, L. B., Jan 1 2024, In: American journal of clinical pathology. 161, 1, p. 60-70 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fluorescence In Situ Hybridization 100%
  • Plasma Cells 98%
  • Immunoglobulins 87%
  • Flow Cytometry 75%
  • Plasma Cell Neoplasms 63%
• 2023

  Anaplastic Kaposi Sarcoma: A Clinicopathologic and Molecular Genetic Analysis

  Fischer, G. M., Gliem, T. J., Greipp, P. T., Rosenberg, A. E., Folpe, A. L. & Hornick, J. L., Aug 2023, In: Modern Pathology. 36, 8, 100191.

  Research output: Contribution to journal › Article › peer-review

  • Kaposi's Sarcoma 100%
  • Molecular Biology 68%
  • HIV 8%
  • Bones of Lower Extremity 7%
  • Hemosiderin 5%

• A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature

  Venable, E. R., Gagnon, M. F., Pitel, B. A., Palmer, J. M., Peterson, J. F., Baughn, L. B., Hoppman, N. L., Greipp, P. T., Ketterling, R. P., Patnaik, M. S., Kelemen, K. & Xu, X., Feb 2023, In: Cold Spring Harbor Molecular Case Studies. 9, 1, a006243.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tyrosine Kinase Inhibitor 100%
  • Gene Fusion 81%
  • Eosinophilia 78%
  • Tyrosine 65%
  • Protein-Tyrosine Kinases 65%

• Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: The Mayo Clinic experience

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Bessonen, K., Gangat, N., Begna, K., Mangaonkar, A., Patnaik, M., Hogan, W. J., Tefferi, A., Litzow, M., Shah, M. V., Yi, C. A., Foran, J., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Apr 25 2023, In: Blood Advances. 7, 8, p. 1351-1355 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Foran, J., Begna, K., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M., Mangaonkar, A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Jan 2023, In: Annals of hematology. 102, 1, p. 211-212 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Conditional survival in multiple myeloma and impact of prognostic factors over time

  Abdallah, N. H., Smith, A. N., Geyer, S., Binder, M., Greipp, P. T., Kapoor, P., Dispenzieri, A., Gertz, M. A., Baughn, L. B., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Dingli, D., Hwa, Y. L., Lin, Y., Kourelis, T., Warsame, R., Kyle, R. A., Rajkumar, S. V. & Kumar, S. K., Dec 2023, In: Blood cancer journal. 13, 1, 78.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Myeloma 100%
  • Survival 56%
  • Chromosomes, Human, Pair 17 9%
  • Proteasome Inhibitors 9%
  • Cytogenetics 7%

• Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

  the International Agency for Research on Cancer/World Health Organization, Sep 2023, In: Leukemia. 37, 9, p. 1944-1951 8 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Lymphoid Leukemia 100%
  • Publications 60%
  • Leukemia 59%
  • Neoplasms 23%

• Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

  Yadav, U., Kumar, S. K., Baughn, L. B., Dispenzieri, A., Greipp, P., Ketterling, R., Jevremovic, D., Buadi, F. K., Dingli, D., Lacy, M. Q., Fonseca, R., Bergsagel, P. L., Ailawadhi, S., Roy, V., Parrondo, R., Sher, T., Hayman, S. R., Kapoor, P., Leung, N., Cook, J., & 13 othersBinder, M., Muchtar, E., Warsame, R., Kourelis, T. V., Go, R. S., Lin, Y., Seth, A., Lester, S. C., Breen, W. G., Kyle, R. A., Gertz, M. A., Rajkumar, S. V. & Gonsalves, W. I., Nov 30 2023, In: Blood. 142, 22, p. 1871-1878 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytogenetics 100%
  • Plasmacytoma 88%
  • Fluorescence In Situ Hybridization 71%
  • Chromosome Aberrations 68%
  • Disease Progression 56%

• Incidental Detection of TFEB-Amplified Renal Cell Carcinoma by Colocated Gene Amplification of CCND3 (6p21): A Case Report and Review of the Literature

  Repetto, F., Sirohi, D., Greipp, P. & Mahlow, J., 2023, (Accepted/In press) In: International Journal of Surgical Pathology.

  Research output: Contribution to journal › Article › peer-review

  • Gene Amplification 100%
  • Renal Cell Carcinoma 82%
  • Genes 19%
  • Cyclin D3 18%
  • Neoplasms 11%

• MDM2 Amplification Status in a Cohort of Well-Characterized Myxofibrosarcoma: A Clinicopathologic Analysis of 22 Tumors

  Dashti, N. K., Jebastin Thangaiah, J., Gliem, T., Knutson, D., Kloft-Nelson, S., Armstrong, S. M., Bakhshwin, A., Greipp, P. & Fritchie, K. J., 2023, (Accepted/In press) In: International Journal of Surgical Pathology.

  Research output: Contribution to journal › Article › peer-review

  • Liposarcoma 100%
  • Myxoid Liposarcoma 59%
  • Neoplasms 31%
  • Recurrence 22%
  • Subcutaneous Tissue 21%

• MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology

  Dutta, A. K., Alberge, J. B., Lightbody, E. D., Boehner, C. J., Dunford, A., Sklavenitis-Pistofidis, R., Mouhieddine, T. H., Cowan, A. N., Su, N. K., Horowitz, E. M., Barr, H., Hevenor, L., Beckwith, J. B., Perry, J., Cao, A., Lin, Z., Kuhr, F. K., Del Mastro, R. G., Nadeem, O., Greipp, P. T., & 4 othersStewart, C., Auclair, D., Getz, G. & Ghobrial, I. M., Feb 1 2023, In: Cancer discovery. 13, 2, p. 348-363 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Circulating Neoplastic Cells 100%
  • Multiple Myeloma 79%
  • Genome 54%
  • Pathology 51%
  • Bone Marrow 44%

• Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma

  Fritchie, K. J., Dermawan, J. K., Astbury, C., Sharma, A., Bakhshwin, A., Fuller, L., Agrawal, S., Wieland, C. N., Greipp, P. T., Azzato, E. M., Folpe, A. L. & Billings, S. D., Aug 2023, In: Virchows Archiv. 483, 2, p. 237-243 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Neurilemmoma 100%
  • High-Throughput Nucleotide Sequencing 49%
  • Skin 47%
  • Fluorescence In Situ Hybridization 34%
  • Gastrointestinal Tract 29%

• Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

  Al-Kali, A., Nanaa, A., Viswanatha, D., He, R., Nguyen, P., Jevremovic, D., Foran, J. M., Yi, C. A., Greipp, P. T., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Badar, T. & Alkhateeb, H. B., Dec 2023, In: Blood cancer journal. 13, 1, 49.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Primary cutaneous gamma/delta T-cell lymphoma with simultaneous JAK2 and TP63 rearrangements: a new double-hit?

  Fadl, A., Bennani, N. N., Comfere, N., Durani, U., Greipp, P. T. & Feldman, A. L., Sep 2023, In: Histopathology. 83, 3, p. 492-495 4 p.

  Research output: Contribution to journal › Letter › peer-review

• Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia

  Pitel, B. A., Zepeda-Mendoza, C., Sachs, Z., Tang, H., Shivaram, S., Sharma, N., Smadbeck, J. B., Smoley, S. A., Pearce, K. E., Luoma, I. M., Cook, J., Litzow, M. R., Hoppman, N. L., Viswanatha, D., Xu, X., Ketterling, R. P., Greipp, P. T., Peterson, J. F. & Baughn, L. B., Dec 2023, In: Blood cancer journal. 13, 1, 138.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia

  Gurney, M., Greipp, P. T., Gliem, T., Knudson, R., Al-Kali, A., Gangat, N., Lasho, T., Mangaonkar, A. A., Finke, C. M. & Patnaik, M. M., Nov 2023, In: Leukemia Research. 134, 107391.

  Research output: Contribution to journal › Letter › peer-review

• The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms

  Gurney, M., Chekkaf, I., Baranwal, A., Basmaci, R., Katamesh, B., Greipp, P., Foran, J. M., Badar, T., Mangaonkar, A. A., Begna, K. H., Gangat, N., Patnaik, M. M., Litzow, M. R., Shah, M. V., Viswanatha, D. S., He, R., Alkhateeb, H. B. & Al-Kali, A., Jul 2023, In: British journal of haematology. 202, 2, p. 279-283 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Mutation 100%
  • Neoplasms 57%
  • Karyotype 52%
  • Primary Myelofibrosis 31%
  • Translational Medical Research 28%

• TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

  Hiwase, D., Hahn, C., Tran, E. N. H., Chhetri, R., Baranwal, A., Al-Kali, A., Sharplin, K., Ladon, D., Hollins, R., Greipp, P., Kutyna, M., Alkhateeb, H., Badar, T., Wang, P., Ross, D. M., Singhal, D., Shanmuganathan, N., Bardy, P., Beligaswatte, A., Yeung, D., & 21 othersLitzow, M. R., Mangaonkar, A., Giri, P., Lee, C., Yong, A., Horvath, N., Singhal, N., Gowda, R., Hogan, W., Gangat, N., Patnaik, M., Begna, K., Tiong, I. S., Wei, A., Kumar, S., Brown, A., Scott, H., Thomas, D., Kok, C. H., Tefferi, A. & Shah, M. V., Mar 2 2023, In: Blood. 141, 9, p. 1087-1091 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

  Shah, M. V., Tran, E. N. H., Shah, S., Chhetri, R., Baranwal, A., Ladon, D., Shultz, C., Al-Kali, A., Brown, A. L., Chen, D., Scott, H. S., Greipp, P., Thomas, D., Alkhateeb, H. B., Singhal, D., Gangat, N., Kumar, S., Patnaik, M. M., Hahn, C. N., Kok, C. H., & 2 othersTefferi, A. & Hiwase, D. K., Dec 2023, In: Blood cancer journal. 13, 1, 51.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Second Primary Neoplasms 100%
  • Gene Frequency 85%
  • Mutation 49%
  • Neoplasms 11%
  • Survival 9%

• Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis

  Gagnon, M. F., Penheiter, A. R., Harris, F., Sadeghian, D., Johnson, S. H., Karagouga, G., McCune, A., Zepeda-Mendoza, C., Greipp, P. T., Xu, X., Ketterling, R. P., McPhail, E. D., King, R. L., Peterson, J. F., Vasmatzis, G. & Baughn, L. B., Dec 2023, In: Blood cancer journal. 13, 1, 190.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Utility of flow cytometry screening before MRD testing in multiple myeloma

  Panakkal, V., Lakshman, A., Shi, M., Olteanu, H., Horna, P., Timm, M. M., Otteson, G. E., Baughn, L. B., Greipp, P. T., Gonsalves, W. I., Kapoor, P., Gertz, M. A., Binder, M., Buadi, F. K., Dispenzieri, A., Rajkumar, S. V., Kumar, S. K. & Jevremovic, D., Dec 2023, In: Blood cancer journal. 13, 1, 55.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2022

  Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients with Clonal Cytopenia of Undetermined Significance

  Jevremovic, D., Nanaa, A., Geyer, S. M., Timm, M., Azouz, H., Hengel, C., Reberg, A., He, R., Viswanatha, D., Salama, M. E., Shi, M., Olteanu, H., Horna, P., Otteson, G., Greipp, P. T., Xie, Z., Alkhateeb, H. B., Hogan, W., Litzow, M., Patnaik, M. M., & 3 othersShah, M., Al-Kali, A. & Nguyen, P. L., Oct 1 2022, In: American journal of clinical pathology. 158, 4, p. 530-536 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Granulocyte Precursor Cells 100%
  • Immunophenotyping 96%
  • HLA-DR Antigens 83%
  • Flow Cytometry 58%
  • Neoplasms 24%

• A Novel USP25::PDGFRA Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm

  Dalland, J. C., Blackburn, P. R., Reichard, K. K., Johnson, S. H., Smadbeck, J. B., Vasmatzis, G., Hoppman, N. L., Xu, X., Greipp, P. T., Baughn, L. B. & Peterson, J. F., Sep 1 2022, In: Laboratory Medicine. 53, 5, p. E134-E138

  Research output: Contribution to journal › Article › peer-review

  • Gene Fusion 100%
  • Eosinophilia 38%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 34%
  • Neoplasms 28%
  • Myeloid Sarcoma 25%

• Apparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL

  Gagnon, M. F., Smadbeck, J. B., Sharma, N., Blackburn, P. R., Demasi Benevides, J., Akkari, Y. M. N., Jaroscak, J. J., Znoyko, I., Wolff, D. J., Schandl, C. A., Meyer, R., Greipp, P. T., Xu, X., Hoppman, N. L., Ketterling, R. P., Peterson, J. F. & Baughn, L. B., 2022, In: Leukemia and Lymphoma. 63, 9, p. 2243-2246 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• A simple additive staging system for newly diagnosed multiple myeloma

  Abdallah, N. H., Binder, M., Rajkumar, S. V., Greipp, P. T., Kapoor, P., Dispenzieri, A., Gertz, M. A., Baughn, L. B., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Dingli, D., Go, R. S., Hwa, Y. L., Fonder, A. L., Hobbs, M. A., Lin, Y., Leung, N., Kourelis, T., Warsame, R., & 6 othersSiddiqui, M. A., Kyle, R. A., Bergsagel, P. L., Fonseca, R., Ketterling, R. P. & Kumar, S. K., Jan 2022, In: Blood cancer journal. 12, 1, 21.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Myeloma 100%
  • Odds Ratio 65%
  • Survival 33%
  • Chromosome Aberrations 19%
  • Patient Selection 17%

• Autoimmune manifestations in STAG2-mutated myeloid neoplasms

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Foran, J., Begna, K., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M., Mangaonkar, A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Dec 2022, In: Annals of hematology. 101, 12, p. 2785-2787 3 p.

  Research output: Contribution to journal › Letter › peer-review

• BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers

  Ida, C. M., Pulido, J., Greipp, P. T., Garcia, J. J., Olsen, T. W., Dalvin, L. & Salomão, D. R., Feb 1 2022, In: Ocular Oncology and Pathology. 8, 1, p. 22-29 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Uveal melanoma 100%
  • Biopsy 45%
  • Melanoma 12%
  • Monosomy 10%
  • Chromosomes, Human, Pair 3 9%

• BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation

  Ghosh, T., Greipp, P. T., Knutson, D., Kloft-Nelson, S., Jenkins, S., Mounajjed, T., Said, S., La Rosa, S., Vanoli, A., Sessa, F., Naini, B. V., Bellizzi, A., Zhang, L., Kerr, S. E. & Graham, R. P., Jul 2022, In: Archives of Pathology and Laboratory Medicine. 146, 7, p. 840-845 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Acinar Cell Carcinoma 100%
  • Pancreatic Carcinoma 82%
  • Fluorescence In Situ Hybridization 46%
  • Mutation 38%
  • Neuroendocrine Carcinoma 14%

• CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma

  Angirekula, M., Chang, S. Y., Jenkins, S. M., Greipp, P. T., Sukov, W. R., Marks, R. S., Olivier, K. R., Cassivi, S. D. & Roden, A. C., May 1 2022, In: Cancers. 14, 9, 2299.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Thymoma 100%
  • Squamous Cell Carcinoma 12%
  • Neoplasms 10%
  • Thymocytes 10%
  • Thymic epithelial tumor 7%

• Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group

  Koleilat, A., Smadbeck, J. B., Zepeda-Mendoza, C. J., Williamson, C. M., Pitel, B. A., Golden, C. L., Xu, X., Greipp, P. T., Ketterling, R. P., Hoppman, N. L., Peterson, J. F., Harrison, C. J., Akkari, Y. M. N., Tsuchiya, K. D., Shago, M. & Baughn, L. B., Dec 2022, In: Genes Chromosomes and Cancer. 61, 12, p. 710-719 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fluorescence In Situ Hybridization 100%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 96%
  • Child 42%
  • Chromosomes 39%
  • Chromosomes, Human, Pair 21 32%

• Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia

  Abdel Rahman, Z. H., Parrondo, R. D., Heckman, M. G., Wieczorek, M., Miller, K. C., Alkhateeb, H., Sproat, L. Z., Murthy, H., Hogan, W. J., Kharfan-Dabaja, M. A., Peterson, J. F., Baughn, L. B., Hoppman, N., Litzow, M. R., Ketterling, R. P., Greipp, P. T. & Foran, J. M., Feb 2022, In: British journal of haematology. 196, 4, p. 963-968 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
  • Odds Ratio 32%
  • Cell Transplantation 27%
  • Residual Neoplasm 27%
  • Plasma Cells 25%

• Comparison between GATA2 and DDX41-mutated myeloid neoplasms

  Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Jevremovic, D., Foran, J. M., Yi, C. A., Greipp, P. T., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Oct 2022, In: Leukemia Research. 121, 106931.

  Research output: Contribution to journal › Letter › peer-review

• Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group (Modern Pathology, (2022), 35, 4, (470-479), 10.1038/s41379-021-00961-0)

  Kanagal-Shamanna, R., Orazi, A., Hasserjian, R. P., Arber, D. A., Reichard, K., Hsi, E. D., Bagg, A., Rogers, H. J., Geyer, J., Darbaniyan, F., Do, K. A., Devins, K. M., Pozdnyakova, O., George, T. I., Cin, P. D., Greipp, P. T., Routbort, M. J., Patel, K., Garcia-Manero, G., Verstovsek, S., & 3 othersMedeiros, L. J., Wang, S. A. & Bueso-Ramos, C., May 2022, In: Modern Pathology. 35, 5, p. 705 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Isochromosomes 100%
  • Biological Products 65%
  • Bone Marrow 48%
  • Pathology 42%
  • Health 32%

• Detection of a Cryptic KMT2A/AFDN Gene Fusion [ins(6;11)(q27;q23q23)] in a Pediatric Patient with Newly Diagnosed Acute Myeloid Leukemia

  Berg, H. E., Greipp, P. T., Baughn, L. B., Falcon, C. P., Jackson, C. C. & Peterson, J. F., Jul 1 2022, In: Laboratory Medicine. 53, 4, p. E95-E99

  Research output: Contribution to journal › Article › peer-review

  • Oncogenic 100%
  • Gene Rearrangement 83%
  • Gene Fusion 80%
  • Acute Myeloid Leukemia 68%
  • Trisomy Chromosome 8 53%

• Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27

  Ding, X., Zakharia, K., Moser, C. D., Campbell, N. A., Hu, C., Razumilava, N., Chaiteerakij, R., Shaleh, H. M., Greipp, P. T., Graham, R. P., Zou, X., Chandan, V. S. & Roberts, L. R., Oct 2022, In: Cancers. 14, 20, 5080.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cholangiocarcinoma 100%
  • Cell Line 51%
  • Biliary Tract Neoplasms 24%
  • Molecular Models 22%
  • Sclerosing Cholangitis 21%

• Gene fusions in gastrointestinal tract cancers

  Rahi, H., Olave, M. C., Fritchie, K. J., Greipp, P. T., Halling, K. C., Kipp, B. R. & Graham, R. P., May 2022, In: Genes Chromosomes and Cancer. 61, 5, p. 285-297 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Gastrointestinal Neoplasms 100%
  • Gene Fusion 95%
  • Chromosome Inversion 26%
  • Digestive System 21%
  • Neoplasms 21%

• Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms

  Alkhateeb, H. B., Nanaa, A., Viswanatha, D., Foran, J. M., Badar, T., Sproat, L., He, R., Nguyen, P., Jevremovic, D., Salama, M. E., Greipp, P., Gangat, N., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Patnaik, M. & Al-Kali, A., Jan 25 2022, In: Blood Advances. 6, 2, p. 528-532 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neoplasms 100%
  • GATA2 Deficiency 95%
  • Germ-Line Mutation 77%
  • Survival 57%
  • Mutation 38%

• Identification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid Leukemia

  Macke, E. L., Meyer, R. G., Hoppman, N. L., Ketterling, R. P., Greipp, P. T., Xu, X., Baughn, L. B., Shafer, D. A., He, R. R. & Peterson, J. F., Jul 1 2022, In: Laboratory Medicine. 53, 4, p. e87-e90

  Research output: Contribution to journal › Article › peer-review

  • Gene Fusion 100%
  • Acute Myeloid Leukemia 84%
  • Metaphase 73%
  • Fluorescence In Situ Hybridization 67%
  • Fluorescence 50%

• Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature

  Gagnon, M. F., Smadbeck, J. B., Vasmatzis, G., Olteanu, H., Wood, A. J., Lewis, D. J., Sharma, N., Meyer, R. G., Greipp, P. T., Xu, X., Hoppman, N. L., Baughn, L. B., Ketterling, R. P., Chiu, A. & Peterson, J. F., Jun 2022, In: Annals of Diagnostic Pathology. 58, 151942.

  Research output: Contribution to journal › Article › peer-review

  • Gene Fusion 100%
  • Hematologic Neoplasms 89%
  • Chromosomes 46%
  • Gene Rearrangement 34%
  • Whole Genome Sequencing 34%

• Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements

  Ocal, J. L., Feldman, A. L., Greipp, P. T. & Rimsza, L. M., Sep 2022, In: Journal of Hematopathology. 15, 3, p. 151-155 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • B-Cell Lymphoma 100%
  • Knowledge Bases 16%
  • Lymphoma, Large B-Cell, Diffuse 15%
  • Fluorescence In Situ Hybridization 13%
  • Non-Hodgkin's Lymphoma 13%

• Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group

  Kanagal-Shamanna, R., Orazi, A., Hasserjian, R. P., Arber, D. A., Reichard, K., Hsi, E. D., Bagg, A., Rogers, H. J., Geyer, J., Darbaniyan, F., Do, K. A., Devins, K. M., Pozdnyakova, O., George, T. I., Cin, P. D., Greipp, P. T., Routbort, M. J., Patel, K., Garcia-Manero, G., Verstovsek, S., & 3 othersMedeiros, L. J., Wang, S. A. & Bueso-Ramos, C., Apr 2022, In: Modern Pathology. 35, 4, p. 470-479 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Isochromosomes 100%
  • Biological Products 65%
  • Bone Marrow 48%
  • Pathology 42%
  • Mutation 37%

• Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series

  Oliveira, J. L., Greipp, P. T., Rangan, A., Jatoi, A. & Nguyen, P. L., Jan 2022, In: Blood cancer journal. 12, 1, 11.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms

  Shah, M. V., Chhetri, R., Dholakia, R., Kok, C. H., Gangat, N., Alkhateeb, H. B., Al-Kali, A., Patnaik, M. M., Baranwal, A., Greipp, P. T., He, R., Begna, K. H., Tiong, I. S., Wei, A. H. & Hiwase, D., Aug 2022, In: American journal of hematology. 97, 8, p. 1013-1022 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • venetoclax 100%
  • Second Primary Neoplasms 71%
  • Survival 27%
  • Acute Myeloid Leukemia 13%
  • Progression-Free Survival 12%

• Prognostic significance of acquired 1q22 gain in multiple myeloma

  Audil, H. Y., Cook, J. M., Greipp, P. T., Kapoor, P., Baughn, L. B., Dispenzieri, A., Gertz, M. A., Buadi, F. K., Lacy, M. Q., Dingli, D., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Muchtar, E., Siddiqui, M., Gonsalves, W. I., Hwa, Y. L., Leung, N., Lin, Y., Kourelis, T. V., & 5 othersWarsame, R., Kyle, R. A., Ketterling, R. P., Rajkumar, S. V. & Kumar, S. K., Jan 1 2022, In: American journal of hematology. 97, 1, p. 52-59 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Myeloma 100%
  • Fluorescence In Situ Hybridization 20%
  • Clonal Evolution 14%
  • Monosomy 14%
  • Trisomy 12%

• Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases

  Reichard, K. K., Tefferi, A., Abdelmagid, M., Orazi, A., Alexandres, C., Haack, J. & Greipp, P. T., Nov 2022, In: Blood cancer journal. 12, 11, 147.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytogenetics 100%
  • Leukemia 83%
  • Mutation 56%
  • Survival 56%
  • venetoclax 26%

• Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors

  Geiersbach, K. B., Gliem, T. J., Jenkins, S. M., Gaitatzes, A. G., Brodersen, P. R., Negro, M. E., Clees, M. J., Swanson, K. E., Boeckman, R. M., Natrop, T. J., Sukov, W. R., Shah, K. K., Greipp, P. T., Rowsey, R. A., Flotte, T. J., Erickson, L. A. & Guo, R., Nov 2022, In: Journal of Molecular Diagnostics. 24, 11, p. 1160-1170 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Single Nucleotide Polymorphism 100%
  • Neoplasms 38%
  • Melanoma 21%
  • Nevus 15%
  • Gene Deletion 14%

• Spurious CD34 expression in B-cell lymphoma due to nonspecific binding to PerCP-Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall

  Shi, M., Timm, M. M., Howard, M. T., Jevremovic, D., Yuan, J., Greipp, P. T., Peterson, J. F., Roh, D. J., Horna, P. & Olteanu, H., Jul 2022, In: Cytometry Part B - Clinical Cytometry. 102, 4, p. 326-328 3 p.

  Research output: Contribution to journal › Letter › peer-review